These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 30054632)

  • 1. Separate and Combined Influence of Cognitive Impairment and Dysarthria on Functional Communication in Multiple Sclerosis.
    Feenaughty L; Tjaden K; Weinstock-Guttman B; Benedict RHB
    Am J Speech Lang Pathol; 2018 Aug; 27(3):1051-1065. PubMed ID: 30054632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceptual measures of speech from individuals with Parkinson's disease and multiple sclerosis: intelligibility and beyond.
    Sussman JE; Tjaden K
    J Speech Lang Hear Res; 2012 Aug; 55(4):1208-19. PubMed ID: 22232396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive-linguistic deficit and speech intelligibility in chronic progressive multiple sclerosis.
    Mackenzie C; Green J
    Int J Lang Commun Disord; 2009; 44(4):401-20. PubMed ID: 19294553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of clear, loud, and slow speech on scaled intelligibility and speech severity in Parkinson's disease and multiple sclerosis.
    Tjaden K; Sussman JE; Wilding GE
    J Speech Lang Hear Res; 2014 Jun; 57(3):779-92. PubMed ID: 24687042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shorter Sentence Length Maximizes Intelligibility and Speech Motor Performance in Persons With Dysarthria Due to Amyotrophic Lateral Sclerosis.
    Allison KM; Yunusova Y; Green JR
    Am J Speech Lang Pathol; 2019 Feb; 28(1):96-107. PubMed ID: 31072158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-task speech performance in multiple sclerosis.
    Feenaughty L
    Mult Scler Relat Disord; 2021 Aug; 53():103077. PubMed ID: 34157630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acoustic and intelligibility characteristics of sentence production in neurogenic speech disorders.
    Weismer G; Jeng JY; Laures JS; Kent RD; Kent JF
    Folia Phoniatr Logop; 2001; 53(1):1-18. PubMed ID: 11125256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Cognitive Impairment and Dysarthria on Spoken Language in Multiple Sclerosis.
    Feenaughty L; Guo LY; Weinstock-Guttman B; Ray M; Benedict RHB; Tjaden K
    J Int Neuropsychol Soc; 2021 May; 27(5):450-460. PubMed ID: 33190658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Articulatory Range of Movement in Individuals With Dysarthria Secondary to Amyotrophic Lateral Sclerosis.
    Lee J; Bell M
    Am J Speech Lang Pathol; 2018 Aug; 27(3):996-1009. PubMed ID: 29800071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Communicative Participation in People with Amyotrophic Lateral Sclerosis.
    Sixt Börjesson M; Hartelius L; Laakso K
    Folia Phoniatr Logop; 2021; 73(2):101-108. PubMed ID: 31918429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurogenic Orofacial Weakness and Speech in Adults With Dysarthria.
    Solomon NP; Makashay MJ; Helou LB; Clark HM
    Am J Speech Lang Pathol; 2017 Aug; 26(3):951-960. PubMed ID: 28763804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examining the effects of multiple sclerosis on speech production: does phonetic structure matter?
    Rosen KM; Goozée JV; Murdoch BE
    J Commun Disord; 2008; 41(1):49-69. PubMed ID: 17509609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceptual assessment of dysarthria: Comparison of a general and a detailed assessment protocol.
    Wannberg P; Schalling E; Hartelius L
    Logoped Phoniatr Vocol; 2016 Dec; 41(4):159-67. PubMed ID: 26443894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate and loudness manipulations in dysarthria: acoustic and perceptual findings.
    Tjaden K; Wilding GE
    J Speech Lang Hear Res; 2004 Aug; 47(4):766-83. PubMed ID: 15324285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosocial Impact of Dysarthria: The Patient-Reported Outcome as Part of the Clinical Management.
    Atkinson-Clement C; Letanneux A; Baille G; Cuartero MC; Véron-Delor L; Robieux C; Berthelot M; Robert D; Azulay JP; Defebvre L; Ferreira J; Eusebio A; Moreau C; Pinto S
    Neurodegener Dis; 2019; 19(1):12-21. PubMed ID: 31112944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Speech and pause characteristics in multiple sclerosis: a preliminary study of speakers with high and low neuropsychological test performance.
    Feenaughty L; Tjaden K; Benedict RH; Weinstock-Guttman B
    Clin Linguist Phon; 2013 Feb; 27(2):134-51. PubMed ID: 23294227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consonant Acoustics in Parkinson's Disease and Multiple Sclerosis: Comparison of Clear and Loud Speaking Conditions.
    Tjaden K; Martel-Sauvageau V
    Am J Speech Lang Pathol; 2017 Jun; 26(2S):569-582. PubMed ID: 28654940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of speaking rate manipulations on acoustic and perceptual aspects of the dysarthria in amyotrophic lateral sclerosis.
    Weismer G; Laures JS; Jeng JY; Kent RD; Kent JF
    Folia Phoniatr Logop; 2000; 52(5):201-19. PubMed ID: 10965174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects of intensive voice treatment (LSVT LOUD
    Boliek CA; Fox CM
    Int J Speech Lang Pathol; 2017 Dec; 19(6):601-615. PubMed ID: 27705010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acoustic-phonetic contrasts and intelligibility in the dysarthria associated with mixed cerebral palsy.
    Ansel BM; Kent RD
    J Speech Hear Res; 1992 Apr; 35(2):296-308. PubMed ID: 1573870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.